Tadashi Imafuku

Years Active: 2020-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Kai Tokumaru, Tadashi Imafuku, Takao Satoh, Tomoaki Inazumi, Shu Hirashima, Ayano Nishinoiri, Taisei Nagasaki, Hitoshi Maeda, Yukihiko Sugimoto, Motoko Tanaka, Kazutaka Matsushita, Toru Maruyama, Hiroshi Watanabe
Omega 3 Fatty Acids Attenuate the Acute Kidney Injury to CKD Transition and Renal Fibrosis: Identification of Antifibrotic Metabolites. Kidney360 (2024)
Tadashi Imafuku, Hiroshi Watanabe, Kentaro Oniki, Akira Yoshida, Hiromasa Kato, Takehiro Nakano, Kai Tokumaru, Issei Fujita, Nanaka Arimura, Hitoshi Maeda, Yuki Sakamoto, Nozomi Kondo, Ayami Morita, Junji Saruwatari, Motoko Tanaka, Kazutaka Matsushita, Takashi Wada, Masafumi Fukagawa, Masaki Otagiri, Michael L Fitzgerald, Hideaki Jinnouchi, Toru Maruyama
Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes. Diabetes care 44 (6) (2021)
Tadashi Imafuku, Hiroshi Watanabe, Takao Satoh, Takashi Matsuzaka, Tomoaki Inazumi, Hiromasa Kato, Shoma Tanaka, Yuka Nakamura, Takehiro Nakano, Kai Tokumaru, Hitoshi Maeda, Ayumi Mukunoki, Toru Takeo, Naomi Nakagata, Motoko Tanaka, Kazutaka Matsushita, Soken Tsuchiya, Yukihiko Sugimoto, Hitoshi Shimano, Masafumi Fukagawa, Toru Maruyama
Advanced Oxidation Protein Products Contribute to Renal Tubulopathy via Perturbation of Renal Fatty Acids. Kidney360 1 (8) (2020)

Tadashi Imafuku.css-eqlu8i{font-size:small;padding-left:4px;}